ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $29,000 | -56.7% | 31,169 | -4.7% | 0.00% | – |
| Q4 2019 | $67,000 | -30.9% | 32,704 | -2.7% | 0.00% | – |
| Q3 2019 | $97,000 | -61.8% | 33,624 | +1.6% | 0.00% | -100.0% |
| Q2 2019 | $254,000 | -41.6% | 33,083 | +1.0% | 0.00% | -50.0% |
| Q1 2019 | $435,000 | -16.2% | 32,746 | -1.8% | 0.00% | 0.0% |
| Q4 2018 | $519,000 | -21.7% | 33,343 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $663,000 | -32.1% | 33,720 | -0.8% | 0.00% | -33.3% |
| Q2 2018 | $976,000 | +49.0% | 33,997 | +22.7% | 0.00% | +50.0% |
| Q1 2018 | $655,000 | -12.4% | 27,697 | -20.6% | 0.00% | 0.0% |
| Q4 2017 | $748,000 | -8.9% | 34,862 | +0.4% | 0.00% | -33.3% |
| Q3 2017 | $821,000 | +26.7% | 34,712 | +5.6% | 0.00% | +50.0% |
| Q2 2017 | $648,000 | +16.5% | 32,873 | +24.1% | 0.00% | 0.0% |
| Q1 2017 | $556,000 | -7.6% | 26,485 | -17.3% | 0.00% | 0.0% |
| Q4 2016 | $602,000 | -99.9% | 32,007 | -1.5% | 0.00% | -33.3% |
| Q3 2016 | $678,663,000 | -18.2% | 32,503 | -0.0% | 0.00% | 0.0% |
| Q2 2016 | $829,346,000 | -4.6% | 32,517 | -1.0% | 0.00% | 0.0% |
| Q1 2016 | $869,000,000 | -35.5% | 32,855 | +4.2% | 0.00% | -50.0% |
| Q4 2015 | $1,348,000,000 | +165705.7% | 31,521 | +2.6% | 0.01% | +50.0% |
| Q3 2015 | $813,000 | -99.9% | 30,712 | +0.6% | 0.00% | 0.0% |
| Q2 2015 | $1,017,765,000 | -3.2% | 30,536 | -3.3% | 0.00% | 0.0% |
| Q1 2015 | $1,051,149,000 | -17.8% | 31,585 | +0.9% | 0.00% | -33.3% |
| Q4 2014 | $1,279,190,000 | +17.2% | 31,299 | -2.8% | 0.01% | +20.0% |
| Q3 2014 | $1,091,275,000 | +1.1% | 32,210 | +0.6% | 0.01% | 0.0% |
| Q2 2014 | $1,079,496,000 | -11.0% | 32,023 | +0.1% | 0.01% | -16.7% |
| Q1 2014 | $1,212,969,000 | +33.4% | 31,996 | +2.7% | 0.01% | +50.0% |
| Q4 2013 | $909,288,000 | -14.2% | 31,140 | +0.7% | 0.00% | -33.3% |
| Q3 2013 | $1,059,678,000 | +2.5% | 30,913 | -1.3% | 0.01% | 0.0% |
| Q2 2013 | $1,033,445,000 | – | 31,326 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |